Human Mixtard 70/30 Suspension for Injection 40IU/ml

Human Mixtard 70/30 Suspension for Injection 40IU/ml – Introduction

Human Mixtard Insulin 30/70 Injection 40IU/ml is a combination of two insulin types – one with an intermediate and another with a short duration of action. This medication is used to manage diabetes mellitus (types 1 and 2) in adults and children, enhancing blood sugar regulation. Its primary function is to help maintain optimal blood sugar levels in individuals with diabetes.

How Human Mixtard 70/30 Suspension for Injection 40IU/ml Works: A Closer Look

Human Mixtard Insulin 30/70 dosage (40IU/ml) comprises two insulin formulations: Insulin Isophane/NPH and Human Insulin/Soluble Insulin. The extended duration of action is attributed to Insulin Isophane/NPH, while Human Insulin/Soluble Insulin contributes to a swift onset of action. Working together, these components ensure prompt and reliable sugar control by facilitating the reuptake of sugar in muscle and fat cells while suppressing sugar production in the liver.

Use

Diabetes

Human Mixtard 70/30 Suspension for Injection 40IU/ml – The Benefits

In Diabetes

Human Mixtard Insulin 30/70 Injection (40IU/ml) combines intermediate-acting and short-acting insulin to ensure effective and consistent control of blood sugar levels throughout the day. Administered through injections, your doctor or nurse will guide the correct injection technique. Maintaining blood glucose levels is crucial to diabetes management, as it reduces the risk of severe complications, including kidney damage, eye issues, nerve problems, and limb loss. This medication, a proper diet, and exercise regimen promote a normal and healthy life.

Human Mixtard 70/30 Suspension for Injection 40IU/ml- A Usage Guide

This medication will be provided by your doctor or nurse. Please refrain from administering it yourself.

Human Mixtard 70/30 Suspension for Injection 40IU/ml – Side Effects

Most side effects resolve independently as your body adapts to the medication and do not require medical attention. If they persist or cause concern, consult your doctor.

Common Side Effects

• Hypoglycemia (low blood glucose level)
• Injection site reactions (pain, swelling, redness)
• Weight gain

[Note: Different drugs can cause varying side effects. To get accurate information about a medication’s specific side effects, refer to the official prescription information or consult your healthcare provider.]

Human Mixtard 70/30 Suspension for Injection 40IU/ml – A Guide to Safety

Alcohol

Unsafe
Drinking alcohol while using Human Mixtard 30 70 40IU Injection is not safe.

Pregnancy

Safe If Prescribed
Mixtard 70/30 Suspension for Injection 40IU/ml is generally considered safe during pregnancy. While animal studies have indicated minimal or no adverse effects on fetal development, there is limited available data from human studies.

Breastfeeding

Safe If Prescribed
Using Human Mixtard 40 IU ML while breastfeeding is deemed safe. Research involving human subjects indicates that the medication is unlikely to pass into breast milk in substantial quantities, posing no harm to the nursing infant.

Driving

Caution
If you experience low or high blood sugar symptoms, refrain from driving, as it may impair your driving ability.

Liver

Caution
Exercise caution when using Human Mixtard 70/30 Suspension for Injection 40IU/ml in individuals with liver disease. Adjustments to the dosage may be necessary, and it is advisable to consult with your doctor. Regular monitoring of glucose levels is recommended to facilitate appropriate dose adjustments.

Kidney

Caution
Exercise caution when administering Human Mixtard 70/30 Suspension for Injection 40IU/ml to patients with kidney disease. Adjustments to the dosage may be necessary, and it is advisable to consult with your doctor. Regular monitoring of blood glucose levels is recommended to facilitate appropriate dose adjustments.

 Fact Box

Swift Advice

• Take the medication 15 minutes before or within 20 minutes after starting a meal.
• Administer injections below the skin of the abdomen for faster absorption than in other sites, such as the upper arms, thighs, or buttocks. Avoid massaging the injection site.
• Rotate injection sites to prevent the development of hard lumps at one location.
• Changing to a different type or brand of insulin should be done under strict medical supervision, as it may necessitate a dosage adjustment.
• Be cautious about potential hypoglycemia when combining the medication with other antidiabetic drugs, alcohol, or when delaying/skipping a meal. Carry a sugar source for immediate relief.
• Avoid sharing insulin devices with others to prevent serious infections, even if the needle is changed.
• Opened vials/cartridges remain viable at room temperature for up to 4 weeks, while unopened vials should be stored in the refrigerator (2°C–8°C).